We celebrated with the Multiple Sclerosis community as TG Therapeutics announced in the final days of 2022 that the FDA approved Briumvi (ublituximab-xiiy), putting the number of available MS disease-modifying therapies to more than 25. Hooray, right? Of course!
But deep down we, as A Couple Takes on MS, still felt somewhat shortchanged.
We selfishly wondered, “When will the announcement come that researchers have developed something (think myelin repair) that can help fix the damage MS has caused to our nervous system over the past two decades?”
Join us in this episode as we discuss the beauty of what Briumvi brings to MS treatment options and then dig into what lies beyond DMTs in the world of what’s next in MS repair and treatment research.
Here are the links to the resource we reference for you to follow up on:
• Repairing What’s Been Lost – National Multiple Sclerosis Society overview of efforts to help restore function.
• Diabetes drug metformin promotes myelin repair in rats – Post from MS Society UK about research that showed how fasting and a diabetes drug had a positive impact in repairing myelin.
• Promising potential of precision medicine in MS care – Post from our blog about the CureTalks online event Transforming Multiple Sclerosis Care Through Precision Medicine where we, along with fellow MS patient advocate and author Melissa Cook, served on a patent panel with Dr. Amit Bar-Or, MD.